Global /Indonesia /Healthcare /Drug Manufacturers - General /KLBF
chevron_leftBack

PT Kalbe Farma Tbk

KLBF
IDX: KLBF Delayed
1,280.00IDR 6.7%
0.0760 USD
As of 24 April 2025, PT Kalbe Farma Tbk has a market cap of $3.27B USD, ranking #3869 globally and #32 in Indonesia. It ranks #326 in the Healthcare sector, and #32 in the Drug Manufacturers - General industry.
Global Rank
3869
Country Rank
32
Sector Rank
326
Industry Rank
32
Key Stats
Market Cap
$3.27BUSD
55.14T IDR
Enterprise Value
$3.12BUSD
52.64T IDR
Revenue (TTM)
$1.94BUSD
32.63T IDR
EBITDA (TTM)
$286.38MUSD
4.83T IDR
Net Income (TTM)
$192.29MUSD
3.24T IDR
EBITDA Margin
15%
Profit Margin
9.9%
PE Ratio
17.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bernadette Ruth Setiady open_in_new
Employees
12,903
Founded
1966
Website
kalbe.co.id open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
6.7% 7.1% 14% 1.6% -24% -8.9%

Markets

Exchange Ticker Price
Indonesia Stock Exchange
MIC: XIDX
PRIMARY
KLBF
ISIN: ID1000125107
Shares Out.:
45.951B1 Shares Float: 18.562B2
TV:
SA:
YF:
GF:
BA:
MS:
1.28K IDR
OTC Markets
MIC: OTCM
PTKFF
ISIN: ID1000125107
TV:
SA:
YF:
GF:
BA:
MS:
0.0751 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About PT Kalbe Farma Tbk

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Similar Companies

Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
Eli Lilly and Co.
LLY
$744.81B
23K%
Johnson & Johnson
JNJ
$374.44B
11K%
AbbVie Inc.
ABBV
$313.2B
9K%
Novo Nordisk A/S
NOVO-B
$276.68B
1.82T DKK
8K%
Roche Holding AG
RO
$246.36B
204.44B CHF
7K%